
€7.50 – €14.50Price range: €7.50 through €14.50
Levetiracetam
SKU: levetiracetam
ACTIVE INGREDIENT: Levetiracetam
OTHER NAMES: (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide, 2(S)-(2-Oxopyrrolidin-1-yl)butyramide; Keppra; Keppra XR; Spritam; UCB 6474; ucb L059; ucb L060; UCB-6474; ucb-L059; ucb-L060; UCB6474; UcbL060;
CAS NUMBER: 102767-28-2
ATC CODE: N03AX14
FORMULA: C8H14N2O2
MOLAR MASS: 170.211 g·mol−1
ITEM TYPE: powder
QUANTITY PER PACK: 2 grams and 5 grams
STORAGE: Best store in a room temperature and dry place. Keep away from direct sunlight and heat. Keep out of reach of children.
SCOOPS: A micro spoon is added to Levetiracetam (0.15 ml) = 75 mg (approximately).
For precise measurement, we recommend using a laboratory scale.
The product is not intended for human use. For collectors, hobbyists, education and research.
All information provided here is for informational purposes only and may contain inaccuracies. These products are intended for collectors, hobbyists, and for educational and research purposes only. Not for use by humans or animals.
While the vast majority of the members of the racetam class family are primarily known for their nootropic potential, levetiracetam happens to be an exception in that it is a second-generation anticonvulsant used to treat epilepsy.
Its mechanisms of action were entirely novel when discovered, earning it the name of “atypical” anticonvulsant. Part of the intrigue is that it remains not fully understood. What is known, however, is that its primary identified target is the Synaptic Vesicle Glycoprotein 2A (SV2A). Levetiracetam binds to this protein, which is involved in the release of neurotransmitters from synaptic vesicles. This is thought to “calm” hyperexcitable neural circuits by modulating synaptic release, not by blocking ion channels like older drugs. The subjective effect users report—reduced “mental static”—aligns perfectly with this neural noise silencing action. It seems to increase the signal-to-noise ratio in the brain without being a sedative or a stimulant. While it doesn’t cause emotional blunting or apathy, it seems to support healthy emotional regulation and lend its users greater volitional control over their affective internal life.
Neurodivergent Conditions: For those with ADHD (especially with comorbid anxiety or epilepsy) and autism, levetiracetam is reported to be a “game-changer.” It doesn’t produce a straightforward, strong mental stimulation with its physiological correlates like methylphenidate or amphetamines, but instead creates a state of quiet mental clarity. It reduces anxiety, intrusive thoughts, and sensory overwhelm, allowing for sustained focus, improved emotional regulation, and supporting healthy, mature executive function.
Many users report a significant reduction in social anxiety and a marked improvement in verbal fluency, word recall, and the ability to articulate complex thoughts smoothly. This makes it a compound of significant interest. Furthermore, levetiracetam might hep mitigate the symptoms of a condition associated with ADHD, probably also highly prevalent in autism spectrum disorder – Rejection Sensitive Dysphoria (RSD) by reducing the intense emotional reactivity to perceived criticism or rejection.
The most commonly mentioned subjective effects of levetiracetam involve the elimination of “brain fog” and “static.” The mind feels quiet, organized, and capable. The effect is often pronounced enough that users notice its absence acutely.